---
title: "NEUMAYER MATTHEW PAUL — Ownership Dossier"
canonical: https://whiteintel.dev/entity/7c56e6e8-e1af-5bfe-8a79-8781fb13611d
json: https://whiteintel.dev/api/public/dossier/7c56e6e8-e1af-5bfe-8a79-8781fb13611d
identifier: sec:0001476315
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# NEUMAYER MATTHEW PAUL

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001476315`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/7c56e6e8-e1af-5bfe-8a79-8781fb13611d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/7c56e6e8-e1af-5bfe-8a79-8781fb13611d  

## Ownership & control

### Holdings / subsidiaries

- **OSIRIS THERAPEUTICS, INC.** (officer) — https://whiteintel.dev/entity/39bacc57-6a50-5c6f-8ae1-eeae8f591f30

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NEUMAYER MATTHEW PAUL**. Human view: https://whiteintel.dev/entity/7c56e6e8-e1af-5bfe-8a79-8781fb13611d · Structured JSON: https://whiteintel.dev/api/public/dossier/7c56e6e8-e1af-5bfe-8a79-8781fb13611d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._